Is Cognex Corp (CGNX) a risky stock?
As of July 22, 2026, Clavix grades Cognex Corp (CGNX) C+ for risk, a composite score of 61 out of 100 on an A+ to F scale, which puts CGNX in the "average" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 22, 2026. Clavix regrades every trading day.
The five risk dimensions behind CGNX's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how CGNX scores on each, as of July 22, 2026.
What's moving CGNX's risk right now
Company-specific signals Clavix flags behind CGNX's current grade, drawn from recent news and filings as of July 22, 2026.
Factory automation and AI machine vision demand have driven Cognex's strong recent run, but analysts say the current valuation may already price in most of the positive outlook, limiting near-term upside.
Cognex was named the best performer among specialized technology stocks in Q1. Separately, a valuation analysis suggests the stock could be roughly 16% undervalued ahead of its August 5 earnings release.
Recent CGNX news
The latest headlines Clavix ingested for Cognex Corp, newest first. These feed the news-sentiment dimension of CGNX's grade.
-
Cognex (CGNX) is scheduled to release its Q2 2026 earnings after market close on August 5, followed by a conference call the next morning. The article suggests the stock could be 16% undervalued heading into the release, with shares at $63.89 and strong recent performance including a 90-day return of 15.12% and a one-year total shareholder return of 90.27%.
What a C+ grade means
On the Clavix A+ to F scale, CGNX's composite of 61 falls in the C band (50–64), read as "average." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell CGNX or any security. Grades are risk indicators, not predictions of return. Data may be delayed.